In fact, demonstrating a rearrangement of MYB, MYBL1, PLAG1, HMGA2, NTRK3, and a BRAF mutation in the appropriate morphological context is diagnostic of adenoid cystic carcinoma, cutaneous mixed tumor, secretory carcinoma, syringocystadenoma papilliferum, and tubular adenoma. This evidence concerns the gene PLAG1 and syringocystadenoma papilliferum.